Drug Price Transparency Clears Second Hurdle

Backers of HB 4005 were able to fight off excessive delays to a bill that would require pharmaceuticals to explain price hikes of over 10 percent per year.

The drug transparency bill passed out of a key budget subcommittee with just minor changes on a 6-2 vote Tuesday, setting up a vote in the Joint Committee on Ways & Means as early as this week.

Source: Drug Price Transparency Clears Second Hurdle | The Lund Report